Recruiting Breast Cancer Studies in New Orleans
DNA-guided Second Line Adjuvant Therapy for High Residual Risk, Estrogen Receptor Positive, HER-2 Negative Breast Cancer (DARE)
A randomized, Phase II trial of circulating tumor DNA-guided second line Adjuvant therapy for high Residual risk, Estrogen Receptor positive, HER-2 negative breast cancer (DARE)...
Clinical Trial of Alpelisb and Tucatinib in Patients With PIK3CA-Mutant HER2+ Metastatic Breast Cancer.
Phase IB/II clinical trial of Alpelisb and Tucatinib in patients with PIK3CA-Mutant HER2-positive metastatic breast cancer....
About Breast Cancer Clinical Trials in New Orleans
Breast cancer is a disease in which cells in the breast grow out of control. It is the most common cancer in women worldwide and can also occur in men. Treatment options include surgery, radiation, chemotherapy, hormone therapy, and targeted therapies.
There are currently 2 breast cancer clinical trials recruiting participants in New Orleans, LA. These studies are seeking a combined 110 participants. Research is being sponsored by Criterium, Inc.. Clinical trial participation is free and participants receive study-related medical care at no cost.
Breast Cancer Clinical Trials in New Orleans — FAQ
Are there breast cancer clinical trials in New Orleans?
Yes, there are 2 breast cancer clinical trials currently recruiting in New Orleans, LA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in New Orleans?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the New Orleans research site will contact you about next steps.
Are clinical trials in New Orleans free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many New Orleans studies also compensate for your time and travel.
What breast cancer treatments are being tested?
The 2 active trials in New Orleans are testing new therapies including novel drugs, biologics, and treatment approaches for breast cancer.
Data updated March 2, 2026 from ClinicalTrials.gov